MedscapeUnivadisEnglish EditionMedscapeUnivadisXPlease confirm that you would like to log out of Medscape.If you log out, you will be required to enter your username and password the next time you visit.>Recent use of selective serotonin reuptake inhibitors (SSRIs) may reduce the treatment response to 3,4-methylenedioxymethamphetamine (MDMA)–assisted psychotherapy for posttraumatic stress disorder (PTSD), even if patients are no longer taking SSRIs.Pooled data from four phase 2 trials reveal that patients with recent SSRI exposure were significantly more likely to continue to meet PTSD...…MedscapeUnivadisEnglish EditionMedscapeUnivadisXPlease confirm that you would like to log out of Medscape.If you log out, you will be required to enter your username and password the next time you visit.>Recent use of selective serotonin reuptake inhibitors (SSRIs) may reduce the treatment response to 3,4-methylenedioxymethamphetamine (MDMA)–assisted psychotherapy for posttraumatic stress disorder (PTSD), even if patients are no longer taking SSRIs.Pooled data from four phase 2 trials reveal that patients with recent SSRI exposure were significantly more likely to continue to meet PTSD...WW…